Most immature T-ALLs express Ra-IL3 (CD123): possible target for DT-IL3 therapy.
Lhermitte
L
L
de Labarthe
A
A
Dupret
C
C
Lapillonne
H
H
Millien
C
C
Landman-Parker
J
J
Hermine
O
O
Baruchel
A
A
Sigaux
F
F
Macintyre
E
E
Asnafi
V
V
D002455:Cell Division; D004167:Diphtheria Toxin / Q000494:pharmacology*; D006801:Humans; D016130:Immunophenotyping; D007377:Interleukin-3 / Q000494:pharmacology*; D053650:Interleukin-3 Receptor alpha Subunit; D015459:Leukemia-Lymphoma, Adult T-Cell / Q000188:drug therapy* / Q000378:metabolism* / Q000473:pathology; D016185:Receptors, Interleukin-3 / Q000378:metabolism*; D011993:Recombinant Fusion Proteins / Q000494:pharmacology*
D004167:Diphtheria Toxin; C115022:IL3RA protein, human; D007377:Interleukin-3; D053650:Interleukin-3 Receptor alpha Subunit; D016185:Receptors, Interleukin-3; D011993:Recombinant Fusion Proteins; C407154:diphtheria toxin-interleukin-3 fusion protein, recombinant